CXCL12 and acute respiratory distress syndrome: Suppression of lactate‐derived lactylation using glycolysis inhibitors ameliorated experimental ARDS and inhibited the release of several chemokines from PECs, especially CXC motif chemokine ligand 12 (CXCL12).